Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Analytical and QC testing supports the development of targeted lentiviral vectors (LVVs) for in vivo CAR-T applications, from early-stage characterization through preclinical studies to GMP-oriented development.
Our approach connects vector quality, safety, targeting performance, and functional activity. Analytical panels are selected according to vector design, development stage, and study objectives—ensuring that data generated at each step builds toward a coherent CMC and regulatory package.
Integrated Analytical Workflow
We establish a stage-appropriate analytical workflow to evaluate targeted LVVs and their biological performance.
This workflow can be adapted to support different stages of targeted LVV-based in vivo CAR-T development.
Vector Quality & Release
Our capabilities cover key physical, molecular, and microbiological attributes of LVV preparations.
Safety & Genomic Characterization
We evaluate vector-associated safety attributes and genomic characteristics relevant to lentiviral vector development.
Potency & Functional Bioanalysis
Our cell-based assays assess vector activity and downstream CAR-T-related functional responses.
Targeting & CAR-Related Assessment
For targeted LVV-based in vivo CAR-T programs, we can evaluate key attributes connecting vector targeting with CAR-T generation and function.
We combine complementary analytical approaches to characterize targeted LVVs across molecular, physicochemical, cellular, functional, and tissue levels.
Molecular Characterization
Physicochemical Characterization
Cell-Based Characterization
Functional Characterization
Tissue-Level Characterization
We assess changes in vector quality and functional activity during storage and following process or manufacturing changes.
Stability Assessment
Comparability Assessment
Testing panels are selected based on the product characteristics and development stage.
Our analytical testing is tailored to the vector characteristics and development stage, supporting targeted LVV programs from early characterization to GMP-oriented development.
Preclinical Development
Early Development
GMP-Oriented Development
Need analytical support for your targeted LVV program? Contact us to discuss how our characterization, potency, and GMP QC capabilities can align with your development stage and regulatory timeline.
Copyright © 2026 Creative Biogene. All rights reserved.